GeneSilico
GeneSilico is an AI-powered precision oncology company focused on expanding access to personalized cancer treatment worldwide. Their flagship platform, gSage, integrates cancer-specific genetic testing with AI-driven insights, combining global oncology expertise, real-world evidence, and the latest research to help oncologists develop optimal, personalized treatment plans at the point of care. The platform addresses the global shortage of oncologists by improving workflow efficiency, reducing administrative burden, and enabling oncologists to treat more patients effectively. GeneSilico's technology is built on a secure, cloud-native AWS infrastructure with advanced AI agents that continuously update treatment options and clinical trial matches. Starting in India with a focus on breast cancer, the company partners with leading cancer centers to pilot and scale its solutions, aiming to improve survivability and quality of life for cancer patients globally.
GeneSilico
GeneSilico is an AI-powered precision oncology company focused on expanding access to personalized cancer treatment worldwide. Their flagship platform, gSage, integrates cancer-specific genetic testing with AI-driven insights, combining global oncology expertise, real-world evidence, and the latest research to help oncologists develop optimal, personalized treatment plans at the point of care. The platform addresses the global shortage of oncologists by improving workflow efficiency, reducing administrative burden, and enabling oncologists to treat more patients effectively. GeneSilico's technology is built on a secure, cloud-native AWS infrastructure with advanced AI agents that continuously update treatment options and clinical trial matches. Starting in India with a focus on breast cancer, the company partners with leading cancer centers to pilot and scale its solutions, aiming to improve survivability and quality of life for cancer patients globally.